Skip to content

AMSMNQ

L'imagerie personnalisée par la médecine nucléaire

  • Accueil
  • Mission
    • Mission de l’AMSMNQ
    • Mission du Comité de DPC de l’AMSMNQ
  • Qui Sommes Nous ?
    • Comité Exécutif
    • Comité du Développement Professionnel Continue (DPC)
    • Comité de la Radioprotection
    • Comité de la Tarification
    • Comité de l’Exercice Professionnel
    • Comité du Site Internet
  • Guide de Pratique
  • Journaux
  • Organisations
  • Partenaires
  • Accès DPC
  • Nous Joindre

    Guide de Pratique

    Posted on 6 janvier 20196 janvier 2019 by admin

    CANM GUIDELINES FOR VENTILATION/PERFUSION (V/P SPECT) IN PULMONARY EMBOLISM

    • Prix AMSMNQ
      • Prix Sanofi-Genzyme
      • Prix Lantheus
      • Prix Financière des Professionnels
    • Colloque 2014 en Photos
    • Colloque 2015 en Photos
    • Colloque 2016 en Photos
    • Colloque 2017 en Photos
    • Colloque 2018 en Photos
    • Colloque 2019 en Photos
    • Automnales
      • Automnale 2014 – L’infection
      • Automnale 2015 – Néoplasie de la Prostate
      • Automnale 2016 -Les Blessures des membres inférieurs chez le sportif
      • Automnale 2017 -Cardiologie : ce que le clinicien veut savoir
      • Automnale 2018 : La douleur lombaire : ce que le clinicien veut savoir .

    Congrès et Colloque à venir

    RSS JNM en Primeur

    • PennPET Explorer: Human Imaging on a Whole-body Imager 15 novembre 2019
    • Prostate-specific membrane antigen guided surgery 15 novembre 2019
    • The path to the future: Education of nuclear medicine therapeutic specialists as responsible physicians 15 novembre 2019
    • PennPET Explorer: Design and Preliminary Performance of a Whole-body Imager 15 novembre 2019
    • Pre-treatment 18F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study 15 novembre 2019
    • Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer 15 novembre 2019
    • Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 (177Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer 15 novembre 2019
    • Trending: Radioactive and fluorescent bimodal/hybrid tracers as multiplexing solutions for surgical guidance 11 novembre 2019
    • Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study 11 novembre 2019
    • Evaluation of dosimetry, quantitative methods and test-retest variability of 18F-PI-2620 PET for the assessment of tau deposits in the human brain 11 novembre 2019
    • Can fluorescence-guided surgery help identify all lesions in unknown locations or is the integrated use of a roadmap created by preoperative imaging mandatory? A blinded study in prostate cancer patients. 11 novembre 2019
    • Head-to-head comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study 1 novembre 2019
    • PARP-1-targeted Auger emitters display high-LET cytotoxic properties in vitro but show limited therapeutic utility in solid tumor models of human neuroblastoma 1 novembre 2019
    • Does 2-FDG-PET Accurately Reflect Quantitative In vivo Glucose Utilization? 1 novembre 2019
    • 18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy 1 novembre 2019

    Info-Lettre AMSMNQ

    Statistiques du Site

    • 1
    • 1
    • 2
    • 104 536

    Facebook AMSMNQ

     

    Copyright © 2019 : AMSMNQ | | Login

    Translate »